annual ROE:
-34.38%-20.37%(-145.40%)Summary
- As of today (June 25, 2025), DNLI annual return on equity is -34.38%, with the most recent change of -20.37% (-145.40%) on December 31, 2024.
- During the last 3 years, DNLI annual ROE has fallen by -6.87% (-24.97%).
- DNLI annual ROE is now -132.02% below its all-time high of 107.38%, reached on December 31, 2015.
Performance
DNLI ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-35.90%-4.53%(-14.44%)Summary
- As of today (June 25, 2025), DNLI quarterly return on equity is -35.90%, with the most recent change of -4.53% (-14.44%) on March 31, 2025.
- Over the past year, DNLI quarterly ROE has dropped by -24.44% (-213.26%).
- DNLI quarterly ROE is now -153.82% below its all-time high of 66.71%, reached on June 30, 2017.
Performance
DNLI quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
DNLI ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -145.4% | -213.3% |
3 y3 years | -25.0% | -27.4% |
5 y5 years | +18.1% | +21.0% |
DNLI ROE Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -145.4% | at low | -213.3% | +10.4% |
5 y | 5-year | -473.3% | +18.1% | -450.9% | +21.6% |
alltime | all time | -132.0% | +18.1% | -153.8% | +79.0% |
DNLI ROE History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | -35.90%(+14.4%) |
Dec 2024 | -34.38%(+145.4%) | -31.37%(-4.7%) |
Sep 2024 | - | -32.93%(-2.1%) |
Jun 2024 | - | -33.63%(+193.5%) |
Mar 2024 | - | -11.46%(-15.1%) |
Dec 2023 | -14.01%(-56.9%) | -13.50%(+11.2%) |
Sep 2023 | - | -12.14%(-7.5%) |
Jun 2023 | - | -13.12%(-67.3%) |
Mar 2023 | - | -40.08%(+13.6%) |
Dec 2022 | -32.52%(+18.2%) | -35.29%(+7.0%) |
Sep 2022 | - | -32.97%(+12.6%) |
Jun 2022 | - | -29.27%(+3.9%) |
Mar 2022 | - | -28.18%(+2.8%) |
Dec 2021 | -27.51%(-398.7%) | -27.40%(-1068.2%) |
Sep 2021 | - | 2.83%(-52.3%) |
Jun 2021 | - | 5.93%(-14.2%) |
Mar 2021 | - | 6.91%(-32.5%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2020 | 9.21%(-121.9%) | 10.23%(-124.8%) |
Sep 2020 | - | -41.22%(-10.0%) |
Jun 2020 | - | -45.80%(+0.8%) |
Mar 2020 | - | -45.44%(+9.1%) |
Dec 2019 | -41.97%(+486.2%) | -41.66%(+207.5%) |
Sep 2019 | - | -13.55%(+22.3%) |
Jun 2019 | - | -11.08%(+9.8%) |
Mar 2019 | - | -10.09%(+39.4%) |
Dec 2018 | -7.16%(-62.2%) | -7.24%(-74.1%) |
Sep 2018 | - | -27.94%(-4.2%) |
Jun 2018 | - | -29.17%(+28.7%) |
Mar 2018 | - | -22.67%(-15.3%) |
Dec 2017 | -18.93%(-120.6%) | -26.77%(-84.3%) |
Sep 2017 | - | -171.04%(-356.4%) |
Jun 2017 | - | 66.71%(+54.4%) |
Mar 2017 | - | 43.20%(+110.1%) |
Dec 2016 | 92.03%(-14.3%) | 20.56% |
Dec 2015 | 107.38% | - |
FAQ
- What is Denali Therapeutics annual return on equity?
- What is the all time high annual ROE for Denali Therapeutics?
- What is Denali Therapeutics annual ROE year-on-year change?
- What is Denali Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Denali Therapeutics?
- What is Denali Therapeutics quarterly ROE year-on-year change?
What is Denali Therapeutics annual return on equity?
The current annual ROE of DNLI is -34.38%
What is the all time high annual ROE for Denali Therapeutics?
Denali Therapeutics all-time high annual return on equity is 107.38%
What is Denali Therapeutics annual ROE year-on-year change?
Over the past year, DNLI annual return on equity has changed by -20.37% (-145.40%)
What is Denali Therapeutics quarterly return on equity?
The current quarterly ROE of DNLI is -35.90%
What is the all time high quarterly ROE for Denali Therapeutics?
Denali Therapeutics all-time high quarterly return on equity is 66.71%
What is Denali Therapeutics quarterly ROE year-on-year change?
Over the past year, DNLI quarterly return on equity has changed by -24.44% (-213.26%)